New study aims to boost cervical cancer care for HIV-Positive women in mozambique
NCT ID NCT06810739
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 4 times
Summary
This study will test a new way to screen and treat cervical cancer in women with HIV in Mozambique. About 8,445 women aged 25-49 who are already receiving HIV care will be offered HPV testing and same-day treatment if needed. The goal is to see if this approach can screen more women and get more of those who test positive treated quickly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS RELATED CERVICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Eduardo Mondlane (UEM)
RECRUITINGMaputo, Mozambique